Science, innovation and commitment

Dr Francesc Palau leads the edition of the new Nelson Pediatric Textbook of Rare Diseases, an international reference work

The head of the Neurogenètica i Medicina Molecular group at the IRSJD is co-editor of the Nelson Pediatric Textbook of Rare Diseases, a new international reference work that brings together the latest advances in genomics, genetic diagnosis and clinical management of paediatric rare diseases.

Sant Joan de Déu leads a European consortium to test a pioneering immunotherapy strategy for the most aggressive and deadly pediatric brain tumor

EPICA - DIPG, a European consortium led by SJD Barcelona Children’s Hospital, ​​launches a five-year project to test an innovative immunotherapy for Diffuse Intrinsic Brainstem Glioma.

A study shows that ACT therapy before surgery improves the recovery of patients with low back pain

A study published in the European Journal of Pain concludes that incorporating a psychological intervention based on Acceptance and Commitment Therapy (ACT) before lumbar surgery can significantly improve patient recovery.

We identify a new cellular mechanism involved in Charcot-Marie-Tooth disease

The results better explain why the mutation of this gene causes the progressive degeneration of peripheral nerves.

Agenda

IV Jornada Científica del IRSJD

Ens plau anunciar-vos la celebració de la V Jornada Científica de l'IRSJD, que tindrà lloc el proper 17 de desembre de 2026 a l'Auditori del Parc Sanitari Sant Joan de Déu.

Auditori del Parc Sanitari Sant Joan de Déu

pendent

Interviews

Susana Ochoa Güerre

Psychologist, head of the Research Group on Etiopathogenesis and Treatment of Severe Mental Disorders (MERITT) at the Institut de Recerca Sant Joan de Déu (IRSJD) and head of research at the Parc Sanitari Sant Joan de Déu (PSSJD).

"Not all psychological treatments work the same for everyone"

Read more More Interviews